NTI 2.53% 8.1¢ neurotech international limited

Ann: NTI to Present at Rett Syndrome Foundation Meeting, page-2

  1. 12,998 Posts.
    lightbulb Created with Sketch. 774
    Regarding Rett Syndrome: I just wonder why NTI would bother to pursue anything in respect to Rett Syndrome - when another Australian company (NEU.AX) and their American partner already have now successfully launched an FDA APPROVED product into the all-important US market?

    wasa

    PS: You can look up the relevant discussion on the NEU HC board.
 
watchlist Created with Sketch. Add NTI (ASX) to my watchlist
(20min delay)
Last
8.1¢
Change
0.002(2.53%)
Mkt cap ! $82.40M
Open High Low Value Volume
8.1¢ 8.6¢ 8.1¢ $218.5K 2.618M

Buyers (Bids)

No. Vol. Price($)
1 4998 8.1¢
 

Sellers (Offers)

Price($) Vol. No.
8.2¢ 303262 2
View Market Depth
Last trade - 15.58pm 18/07/2024 (20 minute delay) ?
NTI (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.